Cell-Penetrating Peptides Enhance Viral Nanoparticle Gene Delivery
Cell-penetrating peptides improve the gene transfer efficiency of virus-based nanoparticles while affecting their stability differently depending on CPP type.
Quick Facts
What This Study Found
CPPs enhance viral nanoparticle gene delivery efficiency, with different CPP types showing distinct effects on nanoparticle activity and stability.
Key Numbers
3/4 CPPs enhanced; R8 destabilized; KH27K aggregated; LAH4 disassembled; FUSO no effect; HS-independent
How They Did This
In vitro gene transfer assays with four different CPPs conjugated to viral nanoparticles, stability assessments.
Why This Research Matters
Viral gene therapy vectors often have limited efficiency. CPPs could boost their performance, making gene therapy more effective at lower doses.
The Bigger Picture
Combining CPPs with viral vectors could improve the next generation of gene therapies for genetic diseases and cancer.
What This Study Doesn't Tell Us
In vitro study. CPP-vector interactions may differ in vivo. Immunogenicity and toxicity not assessed.
Questions This Raises
- ?Which CPP-vector combination provides the best in vivo gene delivery?
- ?Do CPPs affect the immunogenicity of viral vectors?
- ?Can CPP enhancement reduce the viral dose needed for therapeutic effect?
Trust & Context
- Key Stat:
- Enhanced delivery CPPs improved viral nanoparticle gene transfer efficiency in vitro
- Evidence Grade:
- In vitro study comparing multiple CPPs. Informative for optimization but needs in vivo validation.
- Study Age:
- Published in 2020.
- Original Title:
- Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles.
- Published In:
- International journal of pharmaceutics, 576, 119008 (2020)
- Authors:
- Váňová, Jana, Hejtmánková, Alžběta, Žáčková Suchanová, Jiřina, Sauerová, Pavla, Forstová, Jitka, Hubálek Kalbáčová, Marie, Španielová, Hana
- Database ID:
- RPEP-05187
Evidence Hierarchy
Frequently Asked Questions
How do cell-penetrating peptides help gene therapy?
CPPs help therapeutic viral vectors enter cells more efficiently by enhancing membrane crossing. This could make gene therapy work better at lower doses, reducing side effects.
Why test different CPPs?
Different CPPs have different properties — some are better at entering cells, some are more stable, some are less toxic. Finding the right CPP for each viral vector type is important for optimizing gene therapy.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05187APA
Váňová, Jana; Hejtmánková, Alžběta; Žáčková Suchanová, Jiřina; Sauerová, Pavla; Forstová, Jitka; Hubálek Kalbáčová, Marie; Španielová, Hana. (2020). Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles.. International journal of pharmaceutics, 576, 119008. https://doi.org/10.1016/j.ijpharm.2019.119008
MLA
Váňová, Jana, et al. "Influence of cell-penetrating peptides on the activity and stability of virus-based nanoparticles.." International journal of pharmaceutics, 2020. https://doi.org/10.1016/j.ijpharm.2019.119008
RethinkPeptides
RethinkPeptides Research Database. "Influence of cell-penetrating peptides on the activity and s..." RPEP-05187. Retrieved from https://rethinkpeptides.com/research/vanova-2020-influence-of-cellpenetrating-peptides
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.